| |
The PACE Initiative was
launched by the United BioSource Corporation (UBC) in January
2008. The focus of this collaborative effort is to improve the
practicality and efficiency of comparative clinical studies to
address mounting “real-world” evidentiary demands by payers,
clinicians, and policy makers. It was created in the belief that
whereas the comparative effectiveness national agenda must
include comparative and pragmatic trials, traditional approaches
to designing and conducting such trials are too costly, take too
much time and are commonly not answering real world needs. PACE
investigators are exploring the challenges and opportunities, in
particular, of Bayesian and adaptive trial techniques as applied
to real world comparative effectiveness applications.
Use the links above to learn
more about the PACE Initiative or become a "Friend of PACE".
|
|
